Improved patient outcome with smoking cessation: when is it too late?

Smoking is the leading modifiable risk factor for chronic obstructive pulmonary disease (COPD), cardiovascular disease (CVD), and lung cancer. Smoking cessation is the only proven way of modifying the natural course of COPD. It is also the most effective way of reducing the risk for myocardial infarction and lung cancer. However, the full benefits of tobacco treatment may not be realized until many years of abstinence. All patients with COPD, regardless of severity, appear to benefit from tobacco treatment. Similarly, patients with recent CVD events also benefit from tobacco treatment. The risk of total mortality and rate of recurrence of lung cancer is substantially lower in smokers who manage to quit smoking following the diagnosis of early stage lung cancer or small cell lung cancer. Together, these data suggest that tobacco treatment is effective both as a primary and a secondary intervention in reducing total morbidity and mortality related to COPD, CVD, and lung cancer. In this paper, we summarize the evidence for tobacco treatment and the methods by which smoking cessation can be promoted in smokers with lung disease.

[1]  S. Rennard,et al.  Effects of varenicline on smoking cessation in patients with mild to moderate COPD: a randomized controlled trial. , 2011, Chest.

[2]  G. Lamas,et al.  Risk of all-cause mortality, recurrent myocardial infarction, and heart failure hospitalization associated with smoking status following myocardial infarction with left ventricular dysfunction. , 2010, The American journal of cardiology.

[3]  S. Uh,et al.  Effects of Smoking Cessation on Airflow Obstruction and Quality of Life in Asthmatic Smokers , 2010, Allergy, asthma & immunology research.

[4]  R. Hoogenveen,et al.  Long-term effectiveness and cost-effectiveness of smoking cessation interventions in patients with COPD , 2010, Thorax.

[5]  M. Beasley Smoking-related Small Airway Disease—A Review and Update , 2010, Advances in anatomic pathology.

[6]  A. Daley,et al.  Influence of smoking cessation after diagnosis of early stage lung cancer on prognosis: systematic review of observational studies with meta-analysis , 2010, BMJ : British Medical Journal.

[7]  W. Busse,et al.  The effects of inhaled budesonide on lung function in smokers and nonsmokers with mild persistent asthma. , 2009, Chest.

[8]  S. Leatherdale,et al.  Smoking cessation: intentions, attempts and techniques. , 2009, Health reports.

[9]  D. Mannino,et al.  The natural history of chronic airflow obstruction revisited: an analysis of the Framingham offspring cohort. , 2009, American journal of respiratory and critical care medicine.

[10]  C. Duncan,et al.  Sustained-release bupropion for hospital-based smoking cessation: a randomized trial. , 2009, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[11]  J. Kleijnen,et al.  Smoking cessation interventions in COPD: a network meta-analysis of randomised trials , 2009, European Respiratory Journal.

[12]  G. Wesseling,et al.  Efficacy of confronting smokers with airflow limitation for smoking cessation , 2009, European Respiratory Journal.

[13]  A. Malarcher,et al.  Cigarette Smoking Among Adults in the United States , 2008 .

[14]  J. Ryu,et al.  Tobacco smoke-related diffuse lung diseases. , 2008, Seminars in respiratory and critical care medicine.

[15]  J. Ebbert,et al.  Varenicline for tobacco dependence. , 2008, The New England journal of medicine.

[16]  T. Greenhalgh,et al.  Effect on smoking quit rate of telling patients their lung age: the Step2quit randomised controlled trial , 2008, BMJ : British Medical Journal.

[17]  C. Husten,et al.  Cigarette smoking among adults--United States, 2006. , 2007, MMWR. Morbidity and mortality weekly report.

[18]  M. Hasselgren,et al.  Factors related to the level of severity of asthma in primary care. , 2007, Respiratory medicine.

[19]  D. Mannino,et al.  International variation in the prevalence of COPD (The BOLD Study): a population-based prevalence study , 2007, The Lancet.

[20]  E. Israel,et al.  Smoking affects response to inhaled corticosteroids or leukotriene receptor antagonists in asthma. , 2007, American journal of respiratory and critical care medicine.

[21]  H. Itoh,et al.  Changes in HRCT findings in patients with respiratory bronchiolitis-associated interstitial lung disease after smoking cessation , 2007, European Respiratory Journal.

[22]  T. Strine,et al.  The Associations between Smoking, Physical Inactivity, Obesity, and Asthma Severity in the General US Population , 2007, The Journal of asthma : official journal of the Association for the Care of Asthma.

[23]  D. Singer,et al.  Bupropion for smokers hospitalized with acute cardiovascular disease. , 2006, The American journal of medicine.

[24]  S. Yusuf,et al.  Tobacco use and risk of myocardial infarction in 52 countries in the INTERHEART study: a case-control study , 2006, The Lancet.

[25]  L. Pbert Nurse-conducted smoking cessation in patients with COPD, using nicotine sublingual tablets and behavioral support. , 2006, Chest.

[26]  N. Thomson,et al.  Effects of smoking cessation on lung function and airway inflammation in smokers with asthma. , 2006, American journal of respiratory and critical care medicine.

[27]  P. Jakobsson,et al.  The impact of repeated spirometry and smoking cessation advice on smokers with mild COPD , 2006, Scandinavian journal of primary health care.

[28]  P. Tønnesen,et al.  Nurse-conducted smoking cessation in patients with COPD using nicotine sublingual tablets and behavioral support. , 2006, Chest.

[29]  J. Cornuz,et al.  Biomedical risk assessment as an aid for smoking cessation. , 2012, The Cochrane database of systematic reviews.

[30]  E. Wouters,et al.  Efficacy of bupropion and nortriptyline for smoking cessation among people at risk for or with chronic obstructive pulmonary disease. , 2005, Archives of internal medicine.

[31]  R. Adams,et al.  Difficulties identifying and targeting COPD and population-attributable risk of smoking for COPD: a population study. , 2005, Chest.

[32]  P. Paré,et al.  Relationship between reduced forced expiratory volume in one second and the risk of lung cancer: a systematic review and meta-analysis , 2005, Thorax.

[33]  N. Anthonisen,et al.  The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial , 2005 .

[34]  L. Boulet,et al.  Cigarette smoking and asthma: a dangerous mix. , 2005, Canadian respiratory journal.

[35]  Å. Westin,et al.  Effects of smoking cessation and reduction in asthmatics. , 2005, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[36]  M. Jaakkola,et al.  Smoking and asthma in adults , 2004, European Respiratory Journal.

[37]  S. Yusuf,et al.  Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study , 2004, The Lancet.

[38]  Josue P. Keely,et al.  Shape of the relapse curve and long-term abstinence among untreated smokers. , 2004, Addiction.

[39]  Majid Ezzati,et al.  Estimates of global mortality attributable to smoking in 2000 , 2003, The Lancet.

[40]  L. Kuller,et al.  Pulmonary function as a predictor of lung cancer mortality in continuing cigarette smokers and in quitters. , 2003, International journal of epidemiology.

[41]  W. Bailey,et al.  Changes in smoking status affect women more than men: results of the Lung Health Study. , 2003, American journal of epidemiology.

[42]  D. Mannino,et al.  Lung function and mortality in the United States: data from the First National Health and Nutrition Examination Survey follow up study , 2003, Thorax.

[43]  K Larsson,et al.  Not 15 but 50% of smokers develop COPD?--Report from the Obstructive Lung Disease in Northern Sweden Studies. , 2003, Respiratory medicine.

[44]  S. Antoniu,et al.  Hospitalizations and mortality in the Lung Health Study , 2002, Expert review of pharmacoeconomics & outcomes research.

[45]  John E Connett,et al.  Smoking and lung function of Lung Health Study participants after 11 years. , 2002, American journal of respiratory and critical care medicine.

[46]  N. Rigotti,et al.  T REATMENT OF T OBACCO U SE AND D EPENDENCE , 2002 .

[47]  马建新,et al.  用FEV6.0代替FVC诊断气道阻塞和肺功能受限[英]/Swanney MP…∥Am J Respir Crit Care Med. , 2002 .

[48]  A. Trosclair,et al.  Cigarette smoking among adults--United States, 2000. , 2002, MMWR. Morbidity and mortality weekly report.

[49]  N. Rigotti Clinical practice. Treatment of tobacco use and dependence. , 2002, The New England journal of medicine.

[50]  K. J. Macleod,et al.  Smoking and airway inflammation in patients with mild asthma. , 2001, Chest.

[51]  P. Anderson,et al.  Smoking cessation in patients with chronic obstructive pulmonary disease: a double-blind, placebo-controlled, randomised trial , 2001, The Lancet.

[52]  I. Adcock,et al.  Cigarette smoking reduces histone deacetylase 2 expression, enhances cytokine expression, and inhibits glucocorticoid actions in alveolar macrophages. , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[53]  V. Siroux,et al.  Relationships of active smoking to asthma and asthma severity in the EGEA study. Epidemiological study on the Genetics and Environment of Asthma. , 2000, The European respiratory journal.

[54]  Aker,et al.  A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. , 1999, The New England journal of medicine.

[55]  C. Rand,et al.  Effect of weight gain on pulmonary function after smoking cessation in the Lung Health Study. , 1998, American journal of respiratory and critical care medicine.

[56]  N. Anthonisen,et al.  Effects of multiple attempts to quit smoking and relapses to smoking on pulmonary function. Lung Health Study Research Group. , 1998, Journal of clinical epidemiology.

[57]  J Vestbo,et al.  A 15-year follow-up study of ventilatory function in adults with asthma. , 1998, The New England journal of medicine.

[58]  J. E. Anderson,et al.  Transdermal nicotine replacement for hospitalized patients: a randomized clinical trial. , 1998, Preventive medicine.

[59]  W. Bailey,et al.  Effects of Smoking Intervention and the Use of an Inhaled Anticholinergic Bronchodilator on the Rate of Decline of FEV1 , 1994 .

[60]  E. Levin,et al.  The nicotine patch in smoking cessation. A randomized trial with telephone counseling. , 1993, Archives of internal medicine.

[61]  M. Lebowitz,et al.  Smoking cessation and changes in respiratory symptoms in two populations followed for 13 years. , 1993, International journal of epidemiology.

[62]  E. J. Brown,et al.  Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. , 1992, The New England journal of medicine.

[63]  J. Samet The health benefits of smoking cessation. , 1991, The Medical clinics of North America.

[64]  J. Palca Nicotine addiction , 1988, Nature.

[65]  J. Samet,et al.  Salivary cotinine levels and involuntary tobacco smoke exposure in children and adults in New Mexico. , 1987, The American review of respiratory disease.

[66]  R. Peto,et al.  The natural history of chronic airflow obstruction. , 1977, British medical journal.